Citigroup Trims Calyxt (CLXT) Target Price to $13.00

Calyxt (NASDAQ:CLXT) had its price objective reduced by Citigroup from $19.00 to $13.00 in a research report sent to investors on Monday. They currently have a neutral rating on the stock.

A number of other equities analysts have also recently issued reports on the stock. Goldman Sachs Group started coverage on shares of Calyxt in a research report on Friday, September 7th. They set a neutral rating and a $18.00 price objective for the company. Zacks Investment Research upgraded shares of Calyxt from a hold rating to a buy rating and set a $15.00 price objective for the company in a research report on Thursday, October 11th. Finally, Jefferies Financial Group reiterated a buy rating and set a $27.00 price objective on shares of Calyxt in a research report on Thursday, November 15th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company currently has a consensus rating of Buy and an average target price of $21.45.

Shares of Calyxt stock opened at $11.99 on Monday. Calyxt has a twelve month low of $11.25 and a twelve month high of $27.23. The company has a debt-to-equity ratio of 0.17, a quick ratio of 15.01 and a current ratio of 15.01.

Calyxt (NASDAQ:CLXT) last issued its quarterly earnings data on Wednesday, November 14th. The company reported ($0.23) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.06. Calyxt had a negative net margin of 6,256.67% and a negative return on equity of 33.08%. The business had revenue of $0.03 million during the quarter, compared to analysts’ expectations of $0.50 million. Analysts predict that Calyxt will post -0.93 EPS for the current year.

In other Calyxt news, insider Daniel F. Voytas sold 4,666 shares of the business’s stock in a transaction that occurred on Thursday, September 20th. The shares were sold at an average price of $16.00, for a total transaction of $74,656.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Manoj Sahoo sold 2,521 shares of the business’s stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $14.84, for a total transaction of $37,411.64. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 20,553 shares of company stock valued at $303,275. 2.80% of the stock is owned by corporate insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. FMR LLC grew its holdings in Calyxt by 1.1% during the 3rd quarter. FMR LLC now owns 4,851,953 shares of the company’s stock worth $74,089,000 after acquiring an additional 52,654 shares during the last quarter. BlackRock Inc. boosted its stake in shares of Calyxt by 4.0% in the 3rd quarter. BlackRock Inc. now owns 762,532 shares of the company’s stock valued at $11,643,000 after purchasing an additional 28,978 shares during the last quarter. Point72 Asset Management L.P. boosted its stake in shares of Calyxt by 50.0% in the 3rd quarter. Point72 Asset Management L.P. now owns 449,898 shares of the company’s stock valued at $6,870,000 after purchasing an additional 149,898 shares during the last quarter. Columbus Hill Capital Management L.P. boosted its stake in shares of Calyxt by 84.6% in the 3rd quarter. Columbus Hill Capital Management L.P. now owns 308,942 shares of the company’s stock valued at $4,718,000 after purchasing an additional 141,618 shares during the last quarter. Finally, Northern Trust Corp boosted its stake in shares of Calyxt by 12.1% in the 2nd quarter. Northern Trust Corp now owns 63,779 shares of the company’s stock valued at $1,191,000 after purchasing an additional 6,903 shares during the last quarter. 28.42% of the stock is currently owned by hedge funds and other institutional investors.

About Calyxt

Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, improved oil composition canola, herbicide tolerant canola, improved quality alfalfa and herbicide tolerant alfalfa, late blight resistant potatoes, cold storable/reduced browning potatoes, improved protein composition soybeans, drought tolerant soybeans, herbicide tolerant soybeans, and improved yield soybeans.

Featured Article: The risks of owning bonds

Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply